Royalty Pharma plc

RPRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $19.62B

Liabilities Breakdown FY2025

Total Liabilities: $9.91B